Health Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 2, 2022
Health Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD May 31, 2022